Volume 1 Issue 1

Ayahuasca and Treatment of Post-Traumatic Stress Disorder: A Case Report

Anthony Ceman, M.D.

Volume 1 Issue 1

Abstract:

Post-traumatic stress disorder (PTSD) is a psychiatric disorder that affects about 8% of the population in the United States. Conventional treatments for PTSD are a category of medications commonly referred to as antidepressants (selective serotonin reuptake inhibitors and serotoninnorepinephrine reuptake inhibitors) along with psychotherapy. Only two of these medications have received Federal Drug Administration (FDA) approval for PTSD treatment, Sertraline, and Paroxetine2. Current evidence is emerging for the treatment of PTSD symptoms with psychedelic substances, one of which is 3,4-Methylenedioxymethamphetamin (MDMA), with it recently receiving a breakthrough therapy designation from the FDA2. This report describes the case of a male United States military veteran who suffers from PTSD symptoms related to both military experiences and childhood trauma and had resolution of those symptoms after administration of Ayahuasca every 6 months under the guidance of a Shaman in Peru. This case serves to provide evidence for the use of Ayahuasca in the treatment of PTSD.

  • Facebook Social Icon
  • Instagram

©2019 by The Journal of Psychedelic Psychiatry. Proudly created with Wix.com